Pfizer stays the course for 2026 guidance, dulling impact of Q1 earnings

By FinMar NewsMay 5, 2026

The blood thinner Eliquis and breast cancer therapy Ibrance helped bring home a first quarter beat for Pfizer, while the COVID-19 portfolio of Comirnaty and Paxlovid…

Pfizer stays the course for 2026 guidance, dulling impact of Q1 earnings

Energy News

Trump says Exxon and Chevron made ‘too much money’ during Iran conflict

Q&A: What does China’s 15th ‘five-year plan’ for renewables mean for

Tankers near Oman come under fire as Iran threatens shipping routes

Expectations as Okon takes over at Seplat Energy – EnviroNews

Banks News

Billion-dollar property collapse highlights private credit danger

As Northern Colorado Changes, What Businesses Need from Their Bank Hasn’t –

Ethiopia Takes Centre Stage as the 29th Connected Banking Summit &

Clarity Act Could Gain Support After Bank CEOs Call for Changes to Crypto

Real Estate News

HOA financial strain fuels increase in homeowner foreclosures: report

AI is Boosting Real Estate Agent Productivity

DeKalb County Clerk’s Office to offer eRecording for real estate documents

New land tracker pilot reveals cost of rebuilding tribal land bases